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Nearly one in five adults in the United States experience mental illness during a year 
(NAMI). Neurobiological correlates of these diseases may provide treatment options if they are 
better understood. Research has provided evidence supporting p38’s role in many mental health 
disorders. P38 mitogen-activated protein kinases appear frequently in literature regarding cellular 
threats, such as UV irradiation, and subsequently serves various functions including cellular 
death. With respect to neurological and psychiatric disease, many of the observed effects are 
related to structures or substrates that are regulated, at least in part, by p38 or its downstream 
targets.  The goal of this review is to examine the role of p38 in neural function and observable 
behavior as well as to review recent research suggesting a novel pathway through which p38 
may act in response to DNA damage induced by psychological stress. This review will look 
through literature detailing p38’s pathway and its relation to the novel GSK3𝛽 serine site and 
DNA damage to make a case for these kinases’ activity as the underlying mechanism in many 









Introduction to Molecules in the p38 Pathway and Brain Disorders 
 
Diseases of the brain 
With current advances in technology and research methodology, large problems, such as 
diseases, are able to be boiled down to the smallest components, such as an active site on a 
protein. Observing and developing an understanding of all the working parts of cells and all of 
the messenger molecules that drive functioning, is often how treatments are found in the 
psychiatric and larger pharmaceutical field. For example, once it was found that seizures were 
due to hypersynchronous discharge of neurons in a particular region of the cortex, they were able 
to treat seizure disorders with use of pharmaceuticals that activate GABA, which is the brain’s 
main inhibitory neurotransmitter (Bittigau et al., 2002).  
The brain is a system of neurons, their pathways and supporting cells. Within these cells, 
there are a variety of proteins that give rise to pathways and contribute to the intricate 
organization of the brain. Dysfunction or dysregulation in these complexes can lead to many 
disease states, such as Alzheimer’s disease. Alzheimer’s is currently believed to be caused by the 
build-up of proteins, and is well known for its progressive cognitive decline. Huntington’s 
disease is caused by repeats of a protein and leads to break-down of nerve tissue. It is known to 
cause emotional problems and cognitive difficulties (NIH). Parkinson’s disease presents as a 
general loss of motor control, and is caused by a loss of dopaminergic neurons in a brain region 
called the substantia nigra. Mental illness often presents with similar symptoms of the diseases 
mentioned above, though etiologies of these diseases, such as anxiety or depression, remain 
poorly understood in comparison to an illness like Alzheimer’s. 




Mental illnesses affect large portions of the population, and some of these illnesses, such 
as addiction are becoming more and more of a pressing issue. They reduce quality of life, are 
poorly understood, and consequently are poorly managed. Mental illness has a large impact on 
society with respect to health care, and behaviors and other symptoms that result have extreme 
consequences in that some may not be functioning at their peak ability when experiencing a 
mental illness. Everything affects everything else, in one way or another, and having reduced 
functioning in individuals may delay solutions to other problems that are entirely unrelated to 
mental health, but are not wholly unaffected by it. Similarly to how all areas of life seem to play 
some part in each other area, molecules and compounds in biology interact with other substrates 
in some shape or fashion. Stress seems like an obvious precursor to mental illnesses, but exactly 
which substrates and structures are at the root of this pathology are not well characterized. 
Changes in activity at the cellular level may impact cells in a completely different region of the 
body, possibly with hundreds of pathways or compounds in between, but finding the specific 
pathway that seems to be central to mental illness will create novel drug targets, and thus 
improve treatments.  
There are several kinases, such as p38 MAPK and GSK3𝛽that seem to underlie various 
phenotypes seen in mental illness, which can be observed via their activity in neurodegenerative 
diseases, which has symptoms reminiscent of various mental illnesses. It has been seen that p38 
is phosphorylated in response to stressors, with cellular stimuli being well studied in this context. 
P38 can then phosphorylate GSK3, which has known functioning critical to apoptosis. Apoptosis 
and atrophy underlie various brain disorders, and is seen in the brain along with physical 
presentations of behaviors and symptoms that are also seen in mental illness. These two kinases 
may interact together in response to stressors and may lead to morphological changes that 




eventually cause mental illness. In addition to this, DNA damage and subsequent apoptosis may 
be involved with the kinase’s activity underlying various mental illnesses. 
 
P38 Mitogen-activated protein kinases (MAPKs) 
MAPKs are thought of as one of the oldest signal transduction pathways, and they 
regulate cellular functioning such as mitosis, metabolism and cellular death (Widmann et al., 
1999). They function in this capacity due to their activation at times of cell division, cell 
activation or during mitosis or interphase transitions (Her et al., 1991).  In general, kinases are 
enzymes that work by changing the shape of other proteins, which, like other modifications, 
serves to regulate function via the change in structure. There are multiple MAPK pathways, and 
they are divided into different families, including classical MAPKs, C-Jun N-terminal kinases 
(JNK) and p38.  
The p38 MAPKs are most frequently activated by cellular stress such as osmotic heat, 
cytokines and UV radiation. Due to their type of activation, p38 MAPK is sometimes referred to 
as a stress-activated protein kinase (SAPK). This family of kinases, which has four subtypes 
including alpha, beta, gamma and delta, has a variety of critical roles (Ichijo, 1999). P38 alpha 
and beta are expressed throughout the body, whereas gamma and delta have variance in their 
expression dependent on the type of tissue. MAPKs require an activation loop, where a segment 
of amino acids forms a phosphorylation lip that sterically blocks activation by incorrect 
molecules, and only becomes active when there is dual phosphorylation. This family of kinases 
can all be categorized by a threonine-glycine-tyrosine dual phosphorylation motif. This means 
that regulation of p38 requires phosphorylation at both the threonine and tyrosine sites (Hanks & 
Hunter, 1995). P38 is activated by cytokines in the inflammatory response, and can respond to 




hormones as well.  They have been found to be important for the immune response, as p38 is 
active in macrophages and T-cells (Roux & Blenis, 2004).  In general, p38 is extremely versatile 
in its many pathways leading to many different critical functions, so it stands to reason why this 
kinase may be at the root cause in a variety of illnesses. 
P38 MAPKs have been implicated as a site of dysfunction in many pathologies, and 
therefore have been looked at as possible therapeutic drug targets. Since p38 plays a large role in 
things such as cellular death, it may also have a part in the negative effects of psychological 
stress in the context of mental illness, which studies have linked to apoptosis and degeneration. 
While apoptosis, or programmed cell death, is a normal and necessary function, overactivity can 
lead to a plethora of issues, like neurodegenerative diseases (Xia, 1995). Underexpression of 
apoptosis, on the other hand, can lead to issues such as cancer, where cellular growth is 
uninhibited, leading to malignancies. Degeneration in the brain is linked to apoptosis, and 
involves neuronal loss and subsequent deterioration of function that is sometimes seen in 
prolonged or severe mental illness.  
 
Upstream Activators of P38 
         There are a range of stimuli that can activate p38, some of which can activate p38 in 
certain cells, and not in others. For example, insulin can activate p38 in certain types of fat cells, 
but downregulates p38 activity in forebrain neurons of fetal chicks (Heidenreich & Kummer, 
1996). This suggests specificity of p38’s role by location, indicating an importance to 
understanding its role in an individual capacity per tissue where p38 is expressed. Considering 
p38 is highly expressed throughout the brain, it is important to understand its functioning in brain 
tissues. P38 kinases, like all MAPKs, can be activated by MAP kinase kinases (MKKs) which 




are dual kinases, meaning they can behave as both a tyrosine kinase and a serine/threonine 
kinase, the latter of which classifies a p38 kinase. MKKs can phosphorylate hydroxide groups on 
the threonine site and the tyrosine site of a p38 MAPK, which is required for its activation. P38 
is specifically activated by MKK3 and MKK6, though it has been observed that MKK4 can 
assist in the activation of alpha and delta isoforms in specific cellular types (Jiang et al., 1997). 
Further upstream in the p38 pathway are a large range of MKK kinases (MAP3K) that 
relay in one way or another to participate in activating p38 kinase. Overexpression of these 
kinases leads to activation of both the p38 and JNK pathways, providing a plausible reason for 
why these MAPKs are co-activated (Ogura & Kitamura, 1998). TAK1 is an example of one of 
the MAP3Ks; it mediates transduction of signals, and can control transcription as well as 
apoptosis (Moriguchi et al., 1996). ASK1, or apoptosis signal-regulating kinase 1, is a MAP3K 
that can eventually induce apoptosis (Ichijo et al., 1997).  
Upstream of the MAP3Ks are more proteins, such as the Tumor Necrosis Factor (TNF) 
receptor-associated factor-2 (TRAF2), which is an adaptor protein with a TRAF domain that 
facilitates interaction with signaling molecules, such as cell surface receptors. This TRAF 
molecule is expressed throughout the body, whereas others, such as TRAF5, are expressed in 
varying amounts and are known to exist in lower levels in the brain (Ishida et al., 1996). This 
TRAF2 protein responds to proinflammatory cytokines, as well as UV irradiation, both of which 
are considered stress stimuli (Ivanov, Fodstad and Ronai, 2001). Given the variance in what can 
activate P38, even if all stimuli are classified as cellular stress, it makes sense why the different 
isoforms are differently expressed throughout the body leading to the numerous functions this 
MAPK is known to have. 




Glutamate is the brain’s main excitatory neurotransmitter, and research has shown that it 
can activate p38 pathways. Glutamate has many roles, with plasticity and neurotoxicity among 
them. The cell death associated with glutamate has been indicated in diseases such as 
Alzheimer’s. Glutamate activates many things via movement of calcium ions, including p38 
MAPK. This was observed in cerebellar cells, who shared high activation of p38 after glutamate 
treatment, and other stress pathways were activated, but not to the same extent (Kawasaki et al., 
1997). This suggests that it is more specifically the activity of the p38 MAPK pathway that 
serves to carry out apoptosis in response to glutamate. 
P38 is also activated in response to DNA double-strand breaks (DSBs), which can occur 
due to ionizing irradiation, which is gamma or X-ray radiation that carries enough radiation to 
cause electron removal, resulting in a charged atom. It can also occur due to use of some anti-
cancer drugs. This response serves to prevent the continuation of the cell cycle when there is 
DNA damage. The function acts as a G2/M checkpoint, and inactivation of p38 is required for 
the cell to proceed to cellular division. This finding has been observed in lymph cells that are 
located in the thymus (Pedraza-Alva et al., 2006). P38’s activation by DNA damage allows the 
cycle to be delayed, which provides the time needed for the DNA repair to occur. While this 
finding is not specific to the brain, DNA damage has been see in brain tissue, and is commonly 
present in response to oxidative stress. 
Observing what activates p38, and the biological result of the pathway shows how 
involved p38 is with cellular death in various mechanisms and due to a range of causes. This 
could arguably be p38’s main function, given that it is activated by many stress stimuli, and how 
important apoptosis is in the stress response. Cellular death is necessary for the health of the 
organism. Only so many cells can exist in one region at any given point, so if there is cellular 




growth and division, there needs to be cell death as well. Cell death is programmed as a response 
to stress stimuli and subsequent cell damage, but it also occurs in older cells that are no longer 
necessary.  
Cell death that occurs in response to injury, but is not regulated can damage neighboring 
cells via spillage of their damaged contents into the extracellular fluid, thus damaging 
surrounding cells. Apoptosis is specifically programmed cell death, and is controlled in a manner 
that only affects cells that are already damaged, thereby preserving the tissue at large. This is 
managed because the cytoskeleton falls apart and then the membrane surrounding the nucleus 
follows suit, and then DNA is fragmented. Next, the cell surface displays new properties thanks 
to its altered shape that allow for rapid phagocytosis, where the cell is essentially eaten by 
another molecule called a macrophage. This process allows for the cell to be eliminated before it 
can spill any of the toxins to its neighbors, and is critical for overall health. 
Procaspases are activated by adaptor proteins that make a complex out of several of the 
enzymes. This complex’s components then cleave each other, thus activating them in tandem, 
and starting the cascade. Cytochrome c from the mitochondria can also start the apoptotic 
cascade. Caspases are the enzyme behind the cell suicide mechanism, and typically the cleavage 
of one caspase activates the next. This action allows for amplification of the message, as each 
half of the cleaved molecule can activate the next caspase in the cascade (Alberts et al., 2002). 
Bcl-2, which is phosphorylated and inactivated by p38 MAPK, helps to regulate the procaspases 
by blocking the release of cytochrome c from the mitochondria (Hui et al., 2014). This process of 
cellular death happens ubiquitously, and it occurs in the brain as well, as evidenced by a study 
that used p38 inhibition in brain tissue (Evans et al., 2015).  




P38’s functions vary widely, and most activity preceding this kinase in its pathway is 
involved with cellular stress, revealing that this kinase is most commonly activated by cellular 
stress as a category. It is fairly well understood within the context of cancer pathology, as its 
response to cellular stresses and function in cell death are apparent and in general, these two 
occurrences are main components of cancer. Through the different types of upstream activators 
of p38, and the varying ways in which p38 then functions, it seems as though it could have a role 
in any disease where some part of the cell cycle is disrupted, or where cell death implicated. 
 
Downstream of p38 
 P38 cannot directly influence every protein to carry out the functional roles it plays, so 
there are many things downstream of p38 which then in turn carry out some of these functions, 
such as cellular death or cell division. MAPKKs are what activate p38, and then from there p38 
can activate many things, such MNK1 and 2, which controls translation, and MSK1 and 2, which 
are known to regulate transcription factors. All of these targets are directly downstream of p38, 
lead to a variety of functions necessary for life, and are important components in the stress 
pathway (Nadal, Ammerer & Posas, 2011). Inhibition of p38 reveals suppression of many genes, 
such as Bmp2, PGES, Tlr2, IGF binding proteins and more (Zer, Sachs & Shin, 2010). This 
shows how widespread this family of MAPKs effects are, as these affected genes have roles 
ranging from bone development to pain mediation (Zaid, Chantiri & Bassit, 2016 and Park et al., 
2016). It would make sense that when p38 is activated by stress functions like bone development 
are subsequently regulated, as the bones would not want to grow while the body is under stress. 
The cell’s energy needs to be conserved and allocated appropriately to accommodate this stress, 
and cells that would grow and divide may be damaged due to this stress. When under cellular 




stress, an individual may not always feel pain, such as while the sunburn from UV irradiation is 
actually happening. This role p38 has in pain mediation is likely a huge component during the 
stress response, so that the individual can continue about their activity and doesn’t have to be in 
pain for the duration that their cells are stressed. 
MAPK-activated protein kinase (MAPKAPK)-2 is another one of p38’s downstream 
targets, and this is activated by stress and growth factors. In experiments with MAPKAPK2 
deficient mice, it has been observed that this kinase contributes to post-transcriptional regulation 
and modulates mRNA stability (Kotlyarov et al., 1999).  This kinase is considered a part of a cell 
cycle checkpoint, and is specifically functional at the G2/M transition as well as the synthesis 
phase. This means that p38 participates in the many checks a cell must pass before replicating, 
and when this kinase is dysfunctional in can lead to malignant proliferation. Other research on 
this MAPKAPK2 has shown that when absent, cells are over-sensitive to apoptosis (Manke et 
al., 2005).  
P38 has downstream targets involved with interference of binding sites seen in cancer 
pathology, and shows a function of p38 in DNA repair (Lee et al., 2014). Dephosphorylation of 
p38 needs to occur for repair to proceed, and it acts to block repair at stages in the cell cycle 
where it is not yet necessary. While this is specifically seen in cancer cells outside of the brain, it 
does provide a role p38 may have in response to neuronal DNA damage as well. Tau protein 
functions to stabilize parts of the cell, and is mostly found in nerve cells, though is seen in 
support cells, such as oligodendrocytes and astrocytes. Certain types of cellular stress, such as 
glucose deprivation, have been seen to cause p38 to phosphorylate tau (Katome et al., 2013). 
This structural change on tau via phosphorylation likely results in the destabilization of cellular 
components, leading to facilitation of apoptosis. One could even reasonably suggest that the 




DNA damage caused by the destabilization of microtubules is potentially going to cause more 
activation of p38, leading to further apoptosis. 
 
P38 down-regulation 
 P38 activity is modulated by various phosphatases, which, in general, remove a 
phosphate group from a protein. In a sense, they can be thought of as the biochemical opposite of 
a kinase, and phosphatases and kinases have to be in balance for cellular regulation to work. 
There are several protein phosphatases, which are considered to be the generic phosphatases, 
including PP2A and PP2C. These can dephosphorylate both serine and threonine residues. Wild-
type p53-induced phosphatase 1 (Wip1) is a member of the PP2C phosphatases that can 
dephosphorylate various targets, such as p38 and tumor suppressors. Wip1 is observed to be 
necessary for germ cell development, and is therefore important in the Wnt pathway, which 
regulates functions such as cell migration and organogenesis (Cho et al., 2017). The DNA 
damage response is attenuated by Wip1 via dephosphorylation of proteins such as p38 with 
assistance of a tumor suppressor called LZAP (An et al., 2011). This activity of p38 with Wip1 
provides further support of the kinase’s role in response to DNA damage, which has yet to be 
well studied within the brain.  
 Striatal enriched protein tyrosine phosphatases (STEPs) are another protein that can 
dephosphorylate p38 at the tyrosine site. NMDA receptors promote the breakup of STEP61, so 
they initiate the p38 signaling that STEP would otherwise block or downregulate (Xu et al., 
2009). This particular phosphatase helps to regulate synaptic plasticity and is highly expressed in 
spinal cord dorsal horn neurons, which is the location of the first order neuron in the nociceptive, 
or pain, pathway. Research has shown that STEP61 inhibits long-term potentiation in the dorsal 




horns, and suggests that the loss of this function may lead to neuropathic pain (Suo et al., 2017). 
The inhibition of the long-term potentiation is likely the cause of its regulation of synaptic 
plasticity, as this process is considered to be cellular learning. The fact that it is located in a part 
of the pain pathway would suggest that this particular cellular learning may play a role in pain 
sensitivity.   
 
Environmental factors preceding activation of p38 
As aforementioned, p38 responds to cellular stress and while stress can be internal, some 
external factor usually precedes to cause the cellular stress, such as UV irradiation. UV light 
creates single-stranded DNA that is coated with a replication protein (RPA) that activates the 
ATR-Chk1 checkpoint pathway. This DNA damage accumulates, but in insufficient amounts to 
cause cell cycle arrest in that point in the cycle. P38 is phosphorylated in phase G2 of the cycle, 
in response to UV light. This activation, in tandem with the low expression of the ATR pathway 
leads to arrest of cellular progression, thus preventing replication of the damaged cells. This was 
determined by use of p38 inhibitors compared to ATR inhibitors, both of which lead to 
inefficient arrest, but the p38 inhibitor moreso. When these inhibitors were combined, there was 
near-total loss of cell cycle arrest, and Chk1 and p38 dual inhibition lead to even more cells 
passing through the checkpoint, and interestingly p38 together with caffeine lead to a loss of 
arrest comparable to the p38+ATR inhibition combination (Warmerdam et al., 2013).  
Response to heat shock involves cellular protection and re-establishment of homeostasis 
so that enzymatic degradation does not result. Heat shock, which is a result of cellular exposure 
to high temperatures, leads to activation of p38. Heat shock factor (HSF) 1 increases cell survival 
under various stress conditions, and is observed to be activated by p38 phosphorylation at a 




serine site (S326) on the factor, with p38 delta performing phosphorylation at a higher rate than 
the other isoforms (Naidu et al., 2016). Various heat-shock proteins (Hsps) can induce p38 
activation, which has been seen in microglial cells, thereby permitting their activity in the 
neuroprotection after cellular stress, the process of which is implicated in the brain’s defense to 
neurodegenerative diseases (Richter-Landsberg, Wyttenback & Arrigo, 2009). 
Oxidative stress is caused when the body is ill-equipped to balance out free radicals, 
which are highly reactive atoms or molecules due to their unpaired electrons and when 
unchecked lead to harmful effects. This is what eating antioxidants can help prevent, as free 
radicals are commonly reactive oxidant species (ROS), which are necessary second messengers, 
but in high levels lead to cell death and damage. The amount of free radicals can be increased by 
pollutants and other toxins, such as tobacco smoke. ROS can activate p38 MAPKs, which can 
then lead to eventually lead to apoptosis, but in a safer manner for surrounding cells and overall 
health. It has also been observed that p38 mediates antioxidant enzyme expression, thus 
regulating ROS without need to resort to apoptosis (Gutierrez-Uzquiza et al., 2012). Oxidative 
stress is commonly seen in aging brains, indicating that this p38 function is likely in the brain as 
well. 
These various methods of p38 activation from external factors, and the unique 
mechanisms each have further solidifies evidence that p38 is heavily involved in most cellular 
stress responses. The stimuli vary greatly, but p38’s different roles serve similar functions of 
cellular protection, which can take many forms, but primarily is done through cellular death. 
Being stress stimuli, a lot of these p38 activators would lead to cellular death on their own, so 
p38 is primarily there to be able to control the mechanism of apoptosis to ensure healthy cells are 
preserved. This kinase can almost be thought of as a machine in the human body, which serves to 




enact precise and accurate processes and eliminate error, just as a machine exists to facilitate 
various functions, but does so with precision that human error does not allow. 
 
P38 and the stress response 
There is a plethora of evidence showing p38’s role in the stress response to cellular 
stressors. As research on mental illness grows, there is growing evidence to suggest 
psychological stress’ role in mental health. There is also data indicating either a role of apoptosis 
in mental illness pathology, or a role of mental illness leading to apoptosis. While the link is not 
yet clear, this line of evidence could demonstrate a role of p38 in response to psychological 
stressors, and thus a role in mental illness. P38’s activity with Bcl-2 is to help regulate its anti-
apoptotic function by inactiving it and in postmortem studies of bipolar patients, when compared 
to healthy controls, there is reduced expression of Bcl-2 in the frontal cortex. There was also 
evidence of increased expression of pro-apoptotic factors, such as Bax, which p38 is known to 
phosphorylate preceding cellular death (Kim et al., 2010). This suggests that apoptosis was 
increased in those with bipolar disorder, and provides support for this underlying the pathology, 
though this does not specifically show p38’s role in these brains. It is possible that when p38 was 
causing the downregulation of Bcl-2, and the upregulation of Bax, but studies showing this 
specifically would need to be carried out for this link to be supported. 
Studies using variate stressors, which are used in animal studies to create psychological 
stress conditions and to make animal models of mental illness show that stress has an effect on 
p38 expression. Observing regions that were known to be stress sensitive, such as the amygdala, 
bed nucleus of the stria terminalis, and the hippocampus revealed that phosphorylated p38 was 
expressed more in mice who underwent the stress paradigm compared to those who did not. This 




same study showed a behavioral effect of stress, which is interpreted to be increased fear and 
anxiety (Hare, 2015). This observation of a change in behavior, as well as a change in p38 
expression indicates that psychological stress has effects both in the brain and on an observable 
level. Mental illness is noticed and then diagnosed based largely on behavioral changes, and the 
effects stress is seen to have on behavior could suggest that, at least in part, stress can precede 
mental disorders. The finding that p38 is also affected by psychological stress could indicate that 
p38’s activity could be the underlying mechanism in the pathology of mental illness, or at least 
those that can be linked to psychological stress. With the understanding of p38’s response to 
psychological stress, and its role in apoptosis in tandem with reports of downstream target’s 
expression, it would be fitting that p38’s expression underlies pathology of mental illness caused 









Chapter 2.  
GSK3𝛽 Introduction and Molecules in its Pathway 
 
Newly found site for p38 to phosphorylate 
P38 MAPK is abundant in the brain, though the literature on p38 and brain activity or 
behavior is much more limited, as much existing research is in the oncology field. Each of p38’s 
isoforms are found throughout the cortex, the cerebellum, and the hippocampus.  P38 alpha is the 
most abundant form within the brain and is primarily expressed in neuronal cells. Beta is highly 
expressed in both neuronal and glial cells, and is found mainly in the nuclei of neuron cells (Lee 
et al., 2005). This kinase also works at the synapses of neurons, where it is required for the 
induction of long-term depression, which is an important process for learning (Collingridge et 
al., 2010). It is clear that p38’s role in the brain could be as widespread and as necessary as it is 
throughout the body. 
P38’s role in the stress response has been established by many studies, but the specifics 
have remained unclear. It has been hard to differentiate between different kinases considering 
several of them are activated by similar, or even the same, stimuli. Over time more has been 
learned about what specifically precedes p38 activation, and then what exactly activates p38, but 
given the expansive functioning of p38 in various parts of the body, it is clear that there are many 
uncovered mechanisms and substrates, many of which could even prove to be novel drug targets 
in treatment of various diseases. In the last ten years, a novel serine site on glycogen synthase 
kinase (GSK) 3β has been observed, and in response to DNA double strand breaks, it has been 
seen that p38 is what phosphorylates this site. The response when this site is activated by p38 
compared to previously discovered sites are activated by other proteins is different, providing 




further evidence of p38 being distinct from other kinases, and suggesting that the relationship 
between p38 and GSK3 could have a key and distinct part in certain brain functions. 
 
Figure 1. (Thornton et al., 2008) 
This figure shows the distribution of the serine sites in the 
thymus, spleen, kidney and brain. The Serine 389 site is 
mainly found in the brain, with little expression in the thymus, 
less in the spleen and none in the kidney. GSK3𝛽is found in 
all of these tissues, but the serine sites are differentially 
distributed (Thornton et al., 2008). 
 
In mice that had an alanine substitution at the serine 389 site, there was reduced 
neurogenesis secondary to an inability of the protein’s N-terminus domain to carry out inhibition. 
This study also showed that GSK3 needs to be controlled in order to allow for normal dentate 
gyrus volume and hippocampal function. The dentate gyrus is a part of the hippocampus devoted 
in part to new episodic memories (Kondratuik et al, 2013). This suggests that without the novel 
serine 389 site, all inhibition is blocked, leading to an overactive GSK3 which causes decreased 
cell growth and development. 
Compared to other isoforms of GSK, 3 beta is more specific to the brain. This kinase is 
regulated by inhibition, meaning that it is constitutively active. Research has shown that this 
inhibition can be achieved via phosphorylation at the C-terminus, which is carried out by p38 
MAPK. This specifically occurs at the serine 389 (S389) site, which is increased in the brain 
compared to other areas of the body, and also has distinct pattern differences in the nucleus 




compared to serine 9. The S389 site was not seen to be present at all in the kidneys, liver or 
heart, though the serine 9 site was present ubiquitously in all tissues tested. This regulates GSK3 
activity in nucleus and promotes cell survival. The serine site 9 is typically phosphorylated by 
the Akt pathway at the N terminus, so p38’s activity is more specific with relation to GSK3. 
Given the distribution, it is more specific to brain function, and inhibiting p38 does not seem to 
affect serine 9. With use of a p38 inhibitor, they were also able to determine that p38 specifically 
is what phosphorylates the S389 site, in that no other kinases took over p38’s role when inhibited 
(Thornton et al., 2008).   
It is currently still thought that the S9 site is the primary mechanism for GSK3beta 
inhibition, but when this site was replaced by alanine, only small differences were seen with 
respect to certain functions. It has been proposed that the p38 phosphorylation of serine 389 is 
one of the mechanisms by which GSK3 can still be regulated when the primary site is unable to. 
One of the functions may be cell survival, as p38 expression promotes the activity of beta-
catenin, which is known to function in neurogenesis, and is responsive to serine 9 
phosphorylation of GSK3 (Thornton et al., 2008). Although it may be true that serine 389 
phosphorylation serves to replace the functioning of serine 9 phosphorylation, this does not mean 
that S389 does not serve purpose on its own. When serine 389 was replaced with alanine, there 
was significantly higher levels of GSK3 activity, indicating that at baseline phosphorylation of 
this novel serine site is occurring (Thornton et al., 2015). There is also evidence supporting the 
role of this serine site in neurodegeneration, as when phosphorylation of this site is blocked, 
histology reveals there is an abundance of  dark neurons compared to wild type mice (Hare, 
2015). 
 




Figure 2. (Hare, 2015) 
The lower row in this figure shows cells 
from the cortex and regions of the 
hippocampus (CA1 and CA3) of the mice 
with overactivity of GSK3, and the top 
row is in wild type mice. The darker cells 
noted in the lower row are representative of neurodegeneration (Hare, 2015). 
 
While inhibition via phosphorylation at both serine sites is likely, it is possible that the 
novel site would increase GSK3 activity in contrast to the serine 9 site, known to decrease it. 
This would allow both p38’s and GSK3’s apoptotic function to remain consistent in that when 
p38 phosphorylates a downstream target it leads to apoptosis and GSK3 activity is parallel with 
the same. It could also be plausible, that p38’s phosphorylation would inactivate GSK3, but 
when this is happening consistently, other factors then try to correct this and either activate 
GSK3 in an alternative fashion, or carry out apoptosis on their own. This would allow for an 
explanation of how GSK3 activity is associated with neurodegeneration, despite p38’s 
phosphorylation of it and known response to factors that precede the same neurodegeneration. 
 
Glycogen synthase kinase (GSK) 3𝛽 
GSK3𝛽 is another serine/threonine protein kinase and it responds to stimuli that are 
similar to MAPK such as inflammatory cytokines and growth factors. It also responds to 
neurotransmitters, providing this kinase with functions including cellular metabolism, synaptic 
plasticity, as well as neurodegeneration and others. It has been implicated in the pathology of 




Alzheimer’s disease, with noted increased levels of neurofibrillary tangles in response to GSK3 
overexpression. These tangles together with the more widely known beta-amyloid protein 
buildup are thought to be the biological mechanisms of the cognitive symptoms (Farr et al., 
2014).  
This kinase is present throughout tissue, but is abundant in the brain (Woodgett, 1990). 
GSK3 is active at baseline, and needs to be phosphorylated to be inactivated, which is irregular 
for kinases (Lochhead et al., 2006). GSK3 is seen in protein migration, and is needed for 
phosphorylation of postsynaptic density protein 95, important for synaptic strength, to migrate 
and affect long-term depression working with NMDA and AMPA receptors. Long-term 
depression is the opposing function to long-term potentiation, and occurs when the cell firing 
lasts long enough to cause desensitization in the neuron to the stimuli. This activity is both how 
the protein 95 becomes interspersed within the hippocampal neurons, and it destabilizes the 
spines, allowing AMPA to interact easier and cause long-term depression (Nelson et al, 2013). 
GSK3 plays a role in long-term potentiation and long-term depression, which is neuronal 
learning and necessary for plasticity (Peineau et al., 2007).   
Lithium, a known and effective treatment for bipolar disorder, inhibits activity of GSK3, 
which is currently thought to be the drug’s mechanism of action (Stambolic & Woodgett, 1996). 
Lithium chloride is also well-known inhibitor of GSK3, and was used in an experiment that 
found GSK3 to have a mediating role in the oxidative stress resistance, providing more evidence 
for GSK3’s ability to promote cell survival. In this study, it was found that in cells that GSK3 
was inhibited via phosphorylation, there was a higher resistance to oxidative stress (Schafer et 
al., 2004). In spinal cord injury and various diseases, there is underlying stress-induced 
apoptosis, and nerve growth factor is seen to have a neuroprotective effect. In rats with induced 




spinal cord injury, nerve growth factor was given, and GSK3 was observed to be activated 
downstream. This suggests the mechanism of nerve growth factor’s protection is regulated by 
activity of GSK3, thereby showing a neuroprotective effect of the kinase (Zhang et al., 2014). 
This is fitting given its role in plasticity and apoptosis possibly through its inhibition of GSK3, 
which consequently inhibits apoptosis. 
 
Upstream Activators of GSK3𝛽 
While not a lot of upstream activators of GSK3 are known, it is predicted that there are 
many. The Akt pathway is one of the known GSK3 upstream activators, and these pathways 
modulate glycogen synthesis, cell growth and survival. GSK3 activity is blocked by several 
kinases, but most frequently this has been seen to occur through the Akt pathway. Akt is also 
known as protein kinase B, and is a serine/threonine kinase, just as p38 is. This pathway inhibits 
GSK3 by phosphorylation at the serine 9 site, which is considered to be its inhibitory site 
(Frame, Cohen & Biondi, 2001). It is implicated in the pathology of Huntington’s disease, and is 
activated by DNA damage via AMT/ATR kinases. Akt has a role in resistance to these stressors, 
and is indicated in cell survival (Song, Ouyang & Bao, 2005). 
Brain-derived neurotrophic factor has been shown to regulate GSK3 activity, as seen 
when BDNF was inhibited and resulted in GSK3 phosphorylation was reduced, thus promoting 
its activity (Gupta, et al., 2014).  Curcumin is a plant derived molecule that can mitigate 
cognitive impairment in animal models of Alzheimer’s by protecting against the effects of 
plaque buildup. It has been seen to increase BDNF expression, and inhibited effects of GSK3 
dependent phosphorylation on the tau protein, which is implicated as amyloid is in Alzheimer’s 
disease (Hoppe et al, 2013). Given the role of GSK3 and cell proliferation, and the functions of 




BDNF, it would make sense if GSK3 activity regulated BDNF, so the interaction of BDNF and 
GSK3 can seem a little unclear. Studies have shown that GSK3 acts to regulate the signal 
transduction of BDNF more than the actual molecule. GSK3 can regulate the phosphorylative 
activity of BDNF, thus controlling how it communicates (Mai, Jope & Li, 2002). This role that 
GSK3 and BDNF have together provides support for the importance of GSK in cell signaling as 
a whole. Considering the number of things it has been seen to act upon, and how many more it is 
predicted to have activity for, this role in communication could underlie many symptoms both 
internally and behaviors externally. 
 
Downstream Targets of GSK3 
Similar to the upstream activators, a lot of downstream targets of GSK3 are not yet 
known, but it has been estimated that there are a few hundred substrates phosphorylated by 
GSK3, and it is currently the kinase with the highest number of substrates known (Linding et al., 
2007). Cyclin D-dependent kinases (CDKs) are phosphorylated by GSK3 on its threonine-286 
site. The cyclin kinase acts in G1 phase to regulate both DNA replication and synthesis. CDKs 
form in response to growth factors to form active enzymes that suppress growth-suppressive 
function, thus allowing growth. When overexpressed, GSK3 can cause a redistribution of CDK 
from nucleus to cytoplasm (Diehl et al., 1998). This suggests that not only does phosphorylation 
of GSK3 relay messages to regulate growth in the cell cycle, but that it has roles in where other 
proteins are found.  
 The Wnt/beta-catenin pathway is a regulator for growth, differentiation, and survival of 
neurons. Wnt knockout mice show midbrain neuronal loss, and dysregulation of hippocampal 
neurogenesis (Lange et al., 2006). Activation of this pathway can be achieved with GSK3, and 




this promotes neurorestoration and an improvement in motor deficits, suggesting GSK3 can be a 
target for treatment of diseases with motor deficits, such as Parkinson’s (L’Episcopo et al., 
2014). Brain derived neurotrophic factor promotes embryonic spinal cord neuron growth, and 
has been implicated in the functional recovery process following spinal cord injury. Upregulation 
of BDNF leads to upregulation of beta-catenin and down-regulation of GSK3, resulting in the 
promotion of neuronal growth (Yang et al., 2015). Beta-catenin is a protein that is linked to 
GSK3 pathways, and it increases neurogenesis and proliferation in the brain. GSK3 
phosphorylation at the novel serine 389 site was shown to stabilize this protein, and increase 
proliferation in the hippocampus (Zhang et al., 2011). The activation of the Wnt/beta-catenin 
pathway by GSK3, and the fact that an increase in BDNF results in upregulation of beta-catenin 
and downregulation of GSK3, may suggest a negative feedback mechanism of beta-catenin. 
CRMP-2 is only expressed in the brain, and is regulated by GSK3 phosphorylation 
inhibition. CRMP-2 is present to a great extent specifically in axons of growing hippocampal 
neurons, and is observed to be critical for axonal growth (Inagaki et al, 2001). This mechanism 
of GSK3 on CRMP-2 is part of how it regulates neurogenesis, showing that it regulates 
individual components in neurons. GSK3, like p38, has a role in a variety of processes that are 
critical to organism survival. While not a lot is currently known about the pathways, it is clear 
that GSK3 has a large role in apoptotic functioning in response to cellular stress. 
 
DNA damage 
 As previously mentioned, DNA damage, and specifically DNA double strand breaks 
(DSBs), is an activator of p38 and it is also an activator of GSK3. Various stress stimuli create 
DNA damage, and p38 MAPK is activated so that it can function to carry out apoptosis and 




ensure tissue is saved. DSBs are extremely damaging lesions, and are mainly created by radiation 
and chemicals, though can occur due to problems during DNA replication. They can lead to 
permanent cell cycle arrest and mitotic cell death caused by loss of chromosomes. When 
incorrectly repaired, they can lead to malignancies (Olive, 1998).  
 The mechanisms of repairing this damage involve two primary pathways, the 
homologous recombination (HR), and the non-homologous end-joining pathways (NHEJ). The 
former is the preferred pathway, and it provides a highly accurate and template-dependent repair 
mechanism and also duplicates the genome by supporting DNA replication and telomere 
maintenance. This allows for the exchange of genetic material between the homologues, thus 
ridding the cell of the damaged segment (Li & Heyer, 2011). The NHEJ pathway is not limited 
to certain phases like HR is because it does not require the homologous pair that is only active in 
synthesis and G2 phase. This pathway acts by recognizing the DNA end, and assembly of the 
complex here, followed by bridging the DNA ends and promotion of stability. (Davis & Chen, 
2013). 
 Serine 389 knockout mice were observed to have decreased levels of cell fitness in cells 
undergoing repair from DSBs. Previously, phosphorylation of GSK3 was seen to restrict GSK3, 
so this novel site provides a new function of GSK 3 phosphorylation, and also appears to be 
specific to responding to DBSs (Thornton et al., 2015).  Both GSK3 and p38 are observed to be 
elevated in response to DNA damage (Bijor & Jope, 2003 and Wood et al., 2009). P38 is seen to 
accumulate specifically in the nucleus after DNA damage, where GSK3beta is found in 
abundance (Thornton et al., 2015). These findings, taken together, may suggest that the serine 
389 site is the location of the response to DNA damage. 




In the early stages of T cell development, V(D)J recombination occurs to help create the 
diversity in antibodies the body has. In V(D)J recombination, there are double strand breaks that 
are intentional, though still activate p38 in one of the stages of development. Dysregulation here 
interferes with the differentiation of the cells (Thornton et al., 2008). The specific involvement of 
p38 in this response needs to be evaluated more specifically in the brain, though, as it could be 
different than has been observed in T cells. Variate stress was seen to increase p38 expression in 
the BNST, amygdala, frontal cortex and hippocampus. GSK3 activity mirrored these responses, 
and this same study found an increase in a histone’s expression, indicative of DNA damage 
(Hare, 2015). These findings show that in the brain, GSK3 and p38 are closely linked and that 
DNA damage is the likely activator of p38, which will then phosphorylate GSK3 at serine 389. 
 
Figure 3. (Hare, 2015) 
This figure shows the expression of p38 
MAPK in response to exercise and variate 
stress in the amygdala, bed nucleus of the 
stria terminalis, hippocampus and the cortex. 
In the control group, p38 expression is relatively consistent, and in response to stress, p38 is 
consistently more expressed than it is at baseline. Exercise increases p38 expression as well, but 
only significantly in the amygdala, where it caused an increase even more than stress did (Hare, 
2015). This supports the concept that p38 responds to psychological stressors, and considering 
under what circumstances p38 phosphorylates GSK3, would suggest that these types of stress 
can cause DNA damage, and can activate the p38 pathway that leads to apoptosis via GSK3. 
 




GSK3 and Apoptosis 
Similarly to p38, there are various apoptotic pathways where GSK3 is implicated, and the 
exact action of the kinase in apoptosis varies according to these pathways. For example, one 
pathway releases cytochrome c and involves the disintegration of mitochondria, whereas another 
pathway requires activation of death receptors, such as Fas. The former pathway, called the 
intrinsic pathway, can be activated by stress stimuli, such as DNA damage. This pathway targets 
Bcl-2 proteins to carry the messages to the mitochondria for disintegration (Akhtar et al., 2004). 
The other, or extrinsic pathway, involves death domain-containing receptors, homotrimerization 
and then binding to proteins including a caspase to create a complex known as a death-inducing 
signaling complex (Papoff et al., 1999).  
Nuclear factor kB is an anti-apoptotic factor via that also functions in the control of DNA 
transcription and cytokine creation. Pathways inducing this factor, inhibit GSK3, suggesting a 
balance of these two in the regulation of apoptosis. Within the central nervous system, GSK3 is 
indicated as a major contributor of apoptosis, and overexpression is linked to the disruption of 
nuclear factor kB, which then leads to apoptosis. GSK3 blocks transcription that is dependent on 
nuclear factor kB, as well as its binding ability to DNA. This activity prevents the normal 
response to tumor necrosis factor-alpha, which would typically induce the phosphorylation of an 
inhibitory protein bound to nuclear factor, normally releasing the protein. This has been observed 
throughout the brain in cortical astrocytes, which are support cells in the brain (Sanchez et al., 
2003). 
In mice with constitutively active GSK3, there was resulted hippocampal cell death 
indicating apoptosis (Fuster-Matanzo et al., 2011). On a behavioral level, this genotype in mice 
resulted in increased startle amplitude as well as reduced swim mobility (Prickaerts et al., 2006). 




These are characteristics of anxiety and depression, respectively, and may suggest the role of cell 
death in these behaviors, and thus the role in GSK3 phosphorylation in these phenotypes. 
 
Figure 4. (Fuster-Matanzo 
et al., 2011) 
This figure shows the 
number of dead cells, 
indicated by whether they 
are fractin positive, in the dorsal and ventral dentate gyrus (DG), which is an area in the 
hippocampus that has a role in new episodic memories. In those with GSK3 overexpression, 
there was more cell death in the dorsal dentate gyrus (Fuster-Matanzo et al., 2011). 
 
GSK3 and serine 389 
The novel serine site found was only in the brain, indicating that it functions solely in the 
brain. This evidence suggests a distinct role of p38 and GSK3 in the brain, and considering the 
role of these kinases with respect to the stress response, and where psychological stress has 
known effects, this p38 phosphorylation of GSK3 could underlie pathology of mental stress and 
mental illness. In mice with GSK3 that cannot be phosphorylated and is therefore constitutively 
active (KI mice), there were phenotypic differences indicative of exaggerated and 
overgeneralized fear, which are considered anxiety-type behaviors (Hare, 2015). 
These mice had an alanine substitution at serine 389, thus only blocking phosphorylation 
specifically at this site. Compared to wild type mice, they showed increased freezing both to a 
novel context and to the conditioning context where they previously were exposed to tone-shock 




pairings. They also showed more freezing in the final minute of a tone, suggesting prolonged 
fear (Hare, 2015). This shows a specific behavioral function of the serine 389 site, as well as an 
indication that it functions in anxious type behaviors, and could play a role in anxiety pathology 
in addition to that of other mental illness. This same study showed that there was 
neurodegeneration in hippocampus cell samples they stained, but that there was no difference 
between KI and wild type mice in hippocampal-dependent activities, such as spatial tasks (Hare, 
2015). This difference in the tissue but not in the behavior would suggest some role of resistance 
or plasticity, and could theoretically be how people with depression, or other mental illnesses, 
function relatively at the same level as healthy counterparts despite having brain changes 
reminiscent of neurodegenerative diseases, at least for the earlier part of the course in their 
illness. 
GSK3, like p38, serves many functions throughout the body, and is a vital part of many 
necessary processes. P38 and GSK3’s relationship, however, seems to be more specific to the 
brain, and to cell death in neurons. This relationship needs to be further explored so that 
subsequent occurrences and behavioral consequences can be understood. Understanding this 
relationship better could lead to improved understanding, and then treatment, of stress-related 
disorders. While it may seem that phosphorylation of the S389 site would block the degeneration 
and consequent behaviors seen as a result of overactive GSK3, it could be that both over and 
under activity at this site lead to similar morphologies and subsequent behaviors. The balance of 
p38’s phosphorylation of GSK3 may need to be tightly regulated and either direction of 
expression could lead to the same end result, whether that be the result of overcorrection or 
simply both ends of the spectrum leading to the same imbalance preceding the apoptotic 
changes.  





 P38, GSK and DNA damage 
 
GSK3, apoptosis, and stress 
GSK3 activity is closely linked to that of apoptosis and of psychological stress. In 
chronic stress paradigms, there is often a measure of glucocorticoids, which modulate the stress 
response and are increased both in stressed animal models and in those with depression. DEX is 
a glucocorticoid agonist, and is observed to both inhibit cellular proliferation and change the 
phosphorylation capability, thus the activity, of GSK3. It decreases phosphorylation at serine 9, 
which is the inhibitor site of GSK3, and increases it at tyrosine 216, therefore increasing GSK3 
action. Leptin, on the other hand, increases beta-catenin and reverses the effects of DEX (Garza 
et al., 2012). Beta-catenin increases neurogenesis, so increasing GSK3 activity, which 
destabilizes the beta protein, effectively inhibits this function, which DEX seems to do. Due to 
this activity, DEX is a commonly used anti-inflammatory, as it helps to induce apoptosis in a 
controlled manner, and has the ability to induce apoptosis in pancreatic cells with increased 
activation of GSK3 (Guo et al., 2016). These findings suggest that GSK3 may have a role in 
behavioral stress, as a known stress hormone, glucocorticoid, increases GSK3 activity, and 
glucocorticoids are elevated in response to stress and in mental illnesses. 
Fear is a common stressor for animal models, and research has shown that fear learning 
can be attenuated by altering expression of GSK3. This was found with use of sevoflurane, 
which impairs learning, and LiCl, a GSK3 inhibitor, like lithium alone. Sevoflurane alone 
decreased stress-induced fear learning, but when given in tandem with LiCl, this effect was not 
observed (Chen et al., 2015). This finding suggests that GSK3’s role in plasticity is extended to 
the response to stress, and indicates GSK3 is a part of the mechanism in fear learning. It would 




be interesting to see the results of this study using only LiCl, and using the results from Chen et 
al’s research, one could predict that inhibiting GSK3 would cause an increased behavioral 
response to fear. A more detailed mechanism of GSK3 in behavioral stress is not yet known, but 
given the above results and what is known about GSK3 functioning in response to various 
stressors could provide some support for the argument that mental stress causes similar effects as 
cellular stressors, at least within the brain. 
 
P38 and disease with cognitive or neuroanatomical consequences 
When people think of diabetes, not many people think of the effects it has on the brain. 
The brain uses up 90% of the body’s glucose, so it makes sense that the brain is affected by a 
disease with defects in a hormone that allows use of glucose. This is clear in instances of low 
blood sugar, which can be a severe and fatal consequence of diabetes, and can lead to cognitive 
deficiencies followed by coma. Psychomotor deficiencies and reduction in gray matter in select 
regions have been observed in some patients with type I diabetes (Musen et al., 2006). Those that 
have particular difficulties in managing their sugar levels, in that it is chronically too high or too 
low, can have gross brain structure changes over time, affecting their functioning (Brands, et al., 
2006).  Hyperglycemia can also be seen to have cognitive impairments, and high levels of 
glucose are known to activate p38. This increase is seen in areas throughout the brain, such as 
the hippocampus (Ramakrishnan et al., 2005). Diabetes is considered to be a risk factor for 
Alzheimer’s disease, and given information about how the brain may change with diabetes, such 
as atrophy, this is a fitting effect of the long-term disease.  
Hypertension (HTN), or high blood pressure, is a risk factor for strokes, can break down 
the blood-brain barrier, and is commonly thought of as a result of too much stress. People with 




various heart conditions, such as heart attack, where HTN is a risk factor, are often told to try 
and relax more to reduce stress. P38 plays a role in hypertension development, seen in mouse 
models, and suppression of this kinase is seen to improve their survival (Ju et al., 2003). HTN is 
a vascular disease, and because of this, it can disrupt the structure of blood vessels, and can lead 
to a decline in brain functions, as the brain tissue is no different than other areas in the body, in 
that it requires oxygen from the blood supply, and the brain cortex is highly vascularized for this 
function. This cognitive functioning, as well as plasticity, is seen to be improved via inhibition of 
p38 in hypertensive mice (Dai et al., 2016).  This means that blocking p38’s downstream 
function is what blocks the cognitive impairments observed in HTN. 
 
Figure 5. (Dai et al., 2016) 
This figure shows that hypertension reduces 
cognitive ability to some capacity with use of a 
water maze task. P38 KI mice, who had 
mutations at threonine sites, blocking activation 
of p38, were able to perform at the cognitive 
level of the control groups even when they had 
hypertension, indicating a role of p38 in specifically the cognitive effects of hypertension (Dai et 
al., 2016). The role of p38 in cognitive deficits in hypertension could be due to the fact that p38 
can lead to expression of apoptotic factors. The death of cells in the brain would mimic 
neurodegeneration, thus leading to complications, such as cognitive deficits, that mimic 
neurodegenerative diseases. 
 




P38 and neurodegenerative disease 
 Neurodegenerative diseases are characterized by a progressive loss of neurons. They are 
a significant problem, and while a lot of research is done on these illnesses, not a lot of effective 
treatments and solutions exist.  As outlined above, p38 and GSK3 both function in apoptosis, so 
it fits that these kinases would underlie diseases characterized by atrophy. Alzheimer’s disease is 
arguably one of the most studied diseases currently, as our older adult population is so large and 
elder home care poses such a challenge to families and individuals. In models of Alzheimer’s 
disease, it has been observed that there is increased activity of p38, and this is related in a 
progressive manner, seen to increase with duration of exposure to the antibody that makes the 
Alzheimer’s phenotype. Oxidative stress, a known activator of p38, is considered one of the 
earliest pathological changes in Alzheimer’s. Evidence has shown that synaptic loss is correlated 
with the activity of p38, in that increased activity leads to more synaptic loss (Savage et al., 
2002).  
Tau, previously mentioned in the section regarding downstream targets of p38, is a 
protein that is involved in the pathology of both Alzheimer’s and chronic traumatic 
encephalopathy (CTE). The latter is seen in athletes, primarily football players and boxers who 
have experienced multiple concussive events. Tau is hyperphosphorylated and then mislocalized 
leading to neurofibrillary tangles which primarily impair axon functioning, but can have a more 
widespread effect as well (Gyoneva et al., 2015). Both amyloid plaques and tau tangles seen in 
Alzheimer’s are linked by p38 activation caused by oxidative stress, so it seems as though the 
oxidative stress is consistently part of the underlying cause. Oxidative stress activates the p38 
MAPK pathway, suggesting that p38 activity could be altered in this disease, leading to 
dysfunctions downstream, which can cause an array of complications. Possibly this is due to an 




increased oxidative need in times of stress, and then when the brain is not equipped to handle the 
excess oxygen  species, it leads to pathologies via its induction DNA damage and then the p38 
pathway. 
 Huntington’s disease is another neurodegenerative disease, caused by repeats in the 
huntingtin protein. There is an increased binding activity of a subunit of NMDA receptors which 
is part of the cause of an increase NMDA-induced excitotoxicity also observed in this disease. 
Using comparison of p38 to JNK, research was able to parse out a specific role of p38, which 
contributes to the increase of excitotoxicity (Fan et al., 2012). P38 has a role in 
neuroinflammation and the microglial response, both of which are seen in Parkinson’s disease. 
This disease is marked by loss of dopamine in the substantia nigra, but it has been observed that 
there is increased microglial activation more universally in response to oxidative stress and pro-
inflammatory cytokines (Gupta et al., 2010).  
 
GSK3 and neurodegenerative disease 
GSK3 has also been linked to formation of the plaques and neurofibrillary tangles seen in 
Alzheimer’s, and inhibition specifically of the beta isoform of this kinase lead to a reduction in 
the tangles and plaques (Hurtado et al., 2012). Creating a buildup of plaques in lab settings has 
resulted in GSK3 overactivity, and utilizing a GSK3 inhibitor both reduced the plaque buildup, 
and reversed some of the cognitive effects (Avrahami et al., 2013). This activity on tau is 
indicated in both Alzheimer’s disease and CTE. In a postmortem study of ALS, another 
neurodegenerative disease, expression of phosphorylated GSK3b was seen to be significantly 
increased in the hippocampus and temporal cortex, whereas other forms of GSK3 and other 
kinases were not significantly increased (Yang, Leystra-Lantz & Strong, 2008). This suggests 




that specifically the beta isoform of GSK3 is involved in the pathology, which is suitable, 
considering its high expression in the brain. 
 Nuclear factor kB is implicated in various neurodegenerative diseases, such as 
Alzheimer’s, Parkinson’s, Huntington’s, and even in various types of seizures, which, when 
frequent and unregulated can eventually lead to cognitive impairment reminiscent of 
neurodegeneration (Romano et al., 2006). The nuclear factor is disrupted when GSK3 is 
inhibited, and leads to a reduction of nuclear factor’s target proteins. The target proteins are 
important in cell growth, so reducing their expression results in reduced proliferation 
(Mamaghani, Patel & Hedley, 2009). Inhibition of nuclear factor kb is seen in GSK3 related 
apoptosis, further tying GSK to the nuclear factor, and the illnesses it has been implicated in. 
 
Figure 6. (Romano et al., 2011) 
The above figure shows the activity of nuclear factor kB in the 
control, and after low frequency stimulation (LFS) and high 
frequency stimulation (HFS). HFS is known to induce LTP, 
whereas LFS is not, so this suggests NFkb activity in long-
term potentiation and in effect, learning (Romano et al., 2011). 
This role of nuclear factor in learning could be why 
dysregulation of it via GSK over or underexpression can lead to diseases where both learning is 
hindered, and information is forgotten. 
 
There is the idea of a cognitive reserve against neurodegenerative disease, and 
considering GSK3’s role in synaptic plasticity by long-term potentiation and long-term 




depression, GSK3 could be an underlying mechanism of this theory. Inhibition of GSK3 is seen 
to prevent long-term depression (Peineau et al., 2007). This would suggest that dysregulation in 
GSK3 can both result in tau buildup and improper storage of information, both of which could 
underlie symptoms in neurodegenerative disease. When a person has more information to store, 
or has more practice in using this process, it may be observed that they have a better distribution 
of GSK3 and a more resilient and practiced kinase, leading to resiliency against dysregulation of 
GSK3. It is seen that those with a higher level of education have a lower chance of developing 
Alzheimer’s disease, and this could be part of the biological reasoning behind the cognitive 
reserve. 
 Alzheimer’s and other neurodegenerative disease are associated with psychological 
symptoms, such as irritability, aggression and mood instability. A major symptom of CTE is 
depression, and has been the result of suicides in NFL players who were found to have the illness 
upon post-mortem evaluation. While these symptoms may be a reaction to general frustration 
surrounding their cognitive decline and progressive loss of independence, it is likely that the 
symptoms are related to observed brain changes. The brain changes are similar to those seen in 
various mental illnesses, providing support for mental illnesses, such as depression, being mild 
neurodegenerative diseases, in addition to the brain changes, such as in expression of p38 and 
GSK3 being the underlying mechanism of the illnesses and associated behaviors. The fact that 
p38 and GSK3 are both indicated in neurodegenerative disease pathologies would suggest that 








Neurodegenerative disease and DNA damage 
 Amyloid protein, known to aggregate in Alzheimer’s has been observed to precede 
mitochondrial DNA damage. Both elevated levels of DSBs and reduced levels of proteins 
associated with DNA repair processes are observed in Alzheimer’s patients. The repair process 
affected has specifically been noted to be the end joining pathway, which is specific to DSBs 
(Shackelford, 2006). As previously mentioned, GSK3 has a role in cellular survival. This is seen 
in knockout mice, when the S389 site is eliminated. Mice with this genotype have decreased cell 
survival for cells undergoing DNA damage repair, and alternatively, when S389 is 
phosphorylated as a result of B cell activation, there is optimum survival during DNA repair 
(Thornton et al., 2015). These results suggest that GSK3 activity could be the underlying 
mechanism of DNA damage, and considering the role of GSK3 in Alzheimer’s, could 
specifically underlie Alzheimer’s pathology.   
 
Figure 7. (Thornton et al., 2015) 
This figure shows p38 expression to be present only where 
serine 389 is also present, which is in total thymocytes (T), 
double positive (DP) thymocytes, and double negative (DN) 
thymocytes. Mature CD4 and CD8 T cells did not show expression of these factors, though 
GSK3 was present throughout. DN and DP cells are undergoing development, thus they are 
rapidly proliferating, whereas mature cells are not. This may indicate p38 and serine 389 activity 
in proliferation, which was not observed to induce phosphorylation of GSK3, but did increase 
phosphorylation of p38 (Thornton et al., 2015). 
 




 Oxidative stress has been linked to Alzheimer’s disease, and is thought to be one of the 
earliest metabolic signs of the disease as well as one of the primary mechanisms of an aging 
brain. In the aging brain, there is seen to be accumulation of DNA damage in postmortem 
studies, though, to my knowledge no studies have shown DNA damage in depression or anxiety 
(Songin et al., 2007). Oxidative stress leads to DNA damage, suggesting that DNA damage 
precedes Alzheimer’s disease. The exact function of DNA damage in Alzheimer’s or other 
neurodegenerative diseases is not well understood, but a possible role would be the interaction 
between p38, GSK3 and DNA damage. The kinases are both implicated in apoptosis, and are a 
part of the response to DNA damage. Apoptosis is seen in neurodegeneration, suggesting the 









P38 and Mental Illness via Stress 
 
Psychological stress 
 Cellular stress has been discussed at length in this paper, but it is not what is commonly 
thought of when individuals think of stress. In a broad sense, stress is any deviation from 
homeostasis, but this is easier thought of at the cellular level, leaving out the day to day stress 
people feel on a regular basis. The deviation from homeostasis is stressful because it poses a 
threat to our health, so applying this, one could say that psychological, or behavioral, stress is the 
response when something not necessarily physical or tangible threatens our well-being. This 
could be caused by the death of a loved one, a financial burden, workload, divorce or a plethora 
of other life events.  
 In animal studies, there are many behavioral responses to chronic variate stress, which is 
usually a two week paradigm of four or five different stressors given in random order every day 
for that fortnight. Some of these behaviors seen are reduced feeding, increased freezing to a tone 
previously linked to shock, increased freezing to a new context, increased startle amplitude, 
reduced mobility in forced swim, reduced exploration in an open field test, and many other 
measurable effects. These behaviors are why chronic variate stress is used to create animal 
models of depression. They mimic behaviors observed in humans with mental illness, such as 
appetite changes, reduced locomotion and increased fear. 
Stress is currently thought to be the primary cause of depression, which affects many 
individuals, and causes a significantly reduced quality of life. Bearing in mind the brain changes 
associated with stress, it is reasonable to think that in instances where stress is the cause of 
depression, it is specifically these brain changes that cause the illness. On a macroscopic scale, 




studies have shown decreased volume in the hippocampus and medial prefrontal cortex in 
depressed individuals (Savitz & Drevets, 2009). The hippocampus is seen to be affected both by 
stress and in neurodegenerative diseases, with p38 as an underlying mechanism.  Depression can 
lead to other problems, such as addiction, in the most severe of cases can even lead to suicide. 
Depression has been implicated as a risk factor for Alzheimer’s disease, and can exacerbate 
various symptoms of other illnesses, both physical and mental (Butters et al., 2008).  
Stress is not only tied to depression, though, and various mental illnesses appear to have a 
significant link between stress and the course of the illness. Post-traumatic stress disorder is one 
of the more obvious incidences of stress being associated with mental health. An acute, large-
scale stressful or traumatic event precedes this illness, which is associated with symptoms such 
as guilt, anxiety, sleep disturbances and most characteristically, flashbacks. In rat models of 
PTSD, for those who had more PTSD-like responses there was significantly lower levels of p38 
in the hippocampus (Cohen et al., 2011). 
There are a range of anxiety disorders, which can be caused or exacerbated by varying 
things. Some are related to social interactions, and some are even more specific phobias. 
Generalized anxiety disorder is where there is no one particular entity that causes the person to 
feel as anxious as they do. It could be considered that this type of anxiety is marked by an 
inability to discriminate between threatening contexts and non-threatening ones, and this 
overgeneralization of fear is what is used for animal models of anxiety. Symptoms of anxiety 
disorders largely include feeling on edge, restlessness, worrying, irritability and can extend into 
physical symptoms such as heart pounding or nausea. Most of these symptoms are noted in 
response to chronic stress, and the physical symptoms can be tied to irregular peripheral nervous 
system fight or flight activity. Anxiety can be thought of as an improper, or exaggerated fear 




response. Fear conditioning has been studied in depth using rodents, and it has been observed 
that mice that are exposed to chronic variate stress have increased fear responses, such as startle 
amplitude and freezing. Mice who were knocked in for GSK3, which means that GSK3 was 
unable to be phosphorylated, and thus was constantly active, were seen to freeze more than wild 
type mice. They were also observed to have a prolonged fear response, seen in the final minute 
of tone exposure (Thornton et al., 2015). 
Current pharmaceuticals for depression can sometimes serve as anxiolytics, and vice 
versa, which is convenient given the high comorbidity between depression and anxiety, and 
likely demonstrates similar underlying pathology. Irradiation has been noted to block behavioral 
antidepressant effects, linking both anxiety and depression to cellular stress, and thus p38, which 
has been noted in response to irradiation-induced DNA damage (Santorelli et al., 2003). This 
particularly links these two mental illnesses to neurogenesis as well as behaviors such as feeding, 
which is indicative of appetite.  
Stress is a common experience, and many are under stress frequently between work or 
school, interpersonal lives and management of any of life’s mishaps. Considering this, it may 
seem obvious that stress is a predecessor in anxiety and depression, which are two common 
mental illnesses. Schizophrenia, though, is a much less common mental illness, affecting only 
1.1% of the U.S.’s adult population (NIMH). Many theories surround the etiology of this disease, 
and genetics are indicated here moreso than other mental illnesses. Even with genetics thought to 
have a large role, though, stress is indicated as a likely environmental factor. Moving can be an 
extremely stressful occurrence, especially when someone is going to a new country with a very 
different culture than their own. There is a higher incidence of schizophrenia in those who have 
moved countries, than those who have lived in a similar place for the duration of their life. In 




general, the stress of moving can be enough to precede mental illness. This can be seen by the 
number of psychiatric patients seen in hospitals who are foreign to the area in a disproportionate 
number to the diversity seen in the area the hospitals are serving. This, taken with the 
understanding that refugees may never seek treatment for their mental health due to insurance 
complications or fear of immigration laws, implies that this number is extremely 
disproportionate. Schizophrenia is a known neurodegenerative disease, and is associated with 
atrophy in the brain, which as previously mentioned can be related to both p38 MAPK and 
GSK3. 
There is a high comorbidity between mental illnesses, suggesting a common link in their 
cause and resulting symptoms. This high amount of multiple diagnoses in the psychiatric field 
could be due to the fact that symptoms are so similar, and that there is an abundance of overlap. 
Again, though, the behaviors are possibly the same because of the way the body and brain react 
to psychological stressors. The difficulty in distinguishing between mental illnesses is yet 
another reason to attempt to establish biological correlates, as more specific diagnosis can lead to 
more individualized treatments, yielding better outcomes. Stress seems to be a common link at 
the behavioral level, and this review has outlined both p38 and GSK to have diverse roles in the 
response to stress, both on a cellular and psychological level. 
Finding ways to reduce stress before it begins to have deleterious effects and turns into a 
psychiatric illness would likely be an effective approach to lessening the incidence of depression, 
but would be incredibly hard to catch so early on. Considering the low quality of life seen in 
stress-related illnesses, and the fact that suicide is one of the leading causes of death in younger 
age groups, the association between stress, mental illness and brain changes is an important 
subject to focus on.  




P38, GSK and Psychological Stress 
 When people are stressed, there are many behaviors that may result, and there are many 
symptoms that can arise. Common symptoms of stress are poor appetite or overeating, 
concentration difficulty, as well as sleep disturbances. Looking at these behaviors and activity of 
p38 and GSK3 in these symptoms could provide more support of these kinases’ involvement in 
resulting behaviors from stress. Melatonin is a hormone that maintains circadian rhythms, and is 
seen to increase p38 activity (Deng et al., 2016). This could indicate that p38 has a role in sleep 
patterns, and p38 is found to regulate the circadian rhythms by having a consistent pattern, or 
rhythm, of activity (Vitalini et al., 2007). GSK3 also has a role on the circadian rhythm, and is 
seen to shorten the cycle, while lithium will lengthen them, thus restoring them (Hirota et al., 
2008). Overeating and undereating are both observed in response to stress, as well as in 
depression. Inhibition of p38 in rabbits who had a subarachnoid hemorrhage was seen to increase 
their appetite (Zhang et al., 2011). These studies show that these kinases that are so well studied 
in the context of cellular stress have behavioral consequences, and these behaviors are often 
disrupted in response to psychological stress.  
Immune function is seen to decrease in response to stress, and in disorders such as 
depression. While the immune function decrease could be due to poor nutrition, or other forms of 
lack of self-care seen in both stress and mental illness, p38 is directly linked to immune function. 
Macrophages participate in the immune response by functioning as a phagocytic cell. Inhibition 
of p38 is seen to trigger cell death of macrophages in response to a pathogen (Park et al., 2002). 
P38𝛼was the first identified member of the p38 family, and this isoform responds to 
lipopolysaccharide (LPS) stimulation. LPS induces synthesis in a type of white blood cell, called 
neutrophils, which participate in the antiviral response (Malcolm & Worthen, 2003). This link 




between p38 and immune function could potentially explain why immune function is often 
depleted in stressed individuals, though at this point more studies need to be carried out before a 
conclusion like this could be drawn. Psychological stress is known to interrupt immune function, 
and p38 appears to have a role in both stress and immune pathways, so it is reasonable to suggest 
some sort of link could exist. These kinases are abundant in the brain, and considering their 
physiologic role, it is likely that they have a specific function in mental stress in addition to its 
role in physiological stress.  
Often in mental illness, people report difficulty concentrating, and this could be from a 
number of things, such as the feeling of “brain fog” some medications have, but looking at the 
role of p38 in different physical effects associated with concentration difficulty could support 
p38’s role in this symptom, thus indicating that it occurs as a result of the stress response. 
Synaptic dysfunction and behavioral deficits can be attenuated by inhibition of p38 (Munoz, et 
al., 2007). P38 is known to reduce synaptic density, and in dysregulation of the kinase, this 
density loss could be significant, causing changes at the behavioral level. Some studies have 
shown that the density of dendritic spines may be reflective of concentration and processing 
speeds (Zito & Murthy, 2002). This lack of concentration is noted in periods of high stress, and 
is frequently observed in students who feel overwhelmed by their workload, and then report 
being unable to focus.  
 
P38, GSK and the hippocampus 
 Stress leads to an array of neuroanatomical changes, such as within dendritic morphology 
and neuronal circuitry. These changes have been related to p38 and GSK3 in some studies, and 
others have implicated substrates of these kinases, suggesting their pathways have a role. With 




stress, there is a reduction in dendritic length as well as a decrease in the number of branch 
points of a neuron, which results in less connectivity and less communication for the neuron. 
Three weeks of stress has been demonstrated to cause atrophy of CA3 pyramidal neurons in the 
hippocampus (Watanabe, Gould & McEwen, 1992). This is the same area that GSK3 
hyperactivity leads to cell death (Hare, 2015). These neurons are some of the principal neurons 
in the hippocampus, and are critical to its functioning. They have a role in memory, and context 
discrimination, and these neurons specifically are linked to creating high resolution depictions 
for spatial memory (Mizuseki et al., 2012). These structural changes in the brain affect their 
functioning, which can add more stress due to an element of frustration. If a person is having 
difficulty remembering something or concentrating, then this difficulty will likely upset and 
stress them further, creating a cycle of stress that is hard to break.   
There is a region in the hippocampus called the sub-granular zone, and this is one of the 
sites identified in the adult brain that is involved in neurogenesis, or the development of new 
neurons. The neurons here branch out to older neurons in the CA3 field, and these new neurons 
are negatively regulated by stress, which results in a decrease in neurogenesis (Fornal et al., 
2007). In adult mice that lack ample neurogenesis, there is a resulted maladaptive stress response 
that is implicated in various mental illnesses (Snyder et al., 2011). In gross anatomy, there has 
been an overall decrease in hippocampal size seen in individuals who are exposed to stress. In a 
neuroimaging study, regression analysis was used to determine severity of maltreatment or SES 
to define childhood stress and observe its relation to hippocampal volume. Maltreatment was 
able to predict the decrease in volume, whereas other structures, such as the amygdala, did not 
show a size difference, suggesting specificity of gross stress effects on the hippocampus (Lawson 
et al., 2017). This indicates apoptosis and atrophy as underlying morphological changes involved 




in stress, and proposes an unclear role of GSK3, which is known to cause apoptosis when 
overactive. It is also known to be phosphorylated by p38, which occurs after stress that may 
underlie various pathologies, but is currently thought to be an inhibitory mechanism on GSK3. 
This phosphorylation of GSK3 may be an attempt to correct the overexpression and it would be 
prudent to observe a time lapse of degeneration as well as GSK3 phosphorylation to determine 
the order of occurrence. 
The hippocampus has long been a major focal point for scientists, and studies have it 
heavily associated with memory; its components, such as CA3 neurons, are frequently in 
literature associated with stress and depression. Reduced long term potentiation at these neurons 
is demonstrated in brain-derived neurotrophic factor (BDNF) knock-out mice, providing 
evidence for BDNF’s role in learning within this critical region of the hippocampus (Schildt et 
al., 2013). BDNF regulates GSK3, and the latter can also regulate BDNF’s signaling activity, 
suggesting a very close link between these factors, and a role of GSK3 in stress’ effects on the 
hippocampus. When these neurons are inactivated, there is impaired object recognition and 
extended conditioned fear, meaning that the extinction of the fear was impaired, whereas its 
acquisition was not (Heldt et al., 2007). BDNF increases cell survival and plays a role in 
neuroplasticity, and it has been observed, that hippocampal production of BDNF requires p38 
activation (Katoh-Semba, et al., 2009). BDNF’s activity was also blocked in astrocytes by a p38 
inhibitor (Rao et al., 2007). 
 Behaviorally, stress paradigms precede poor performance in spatial memory tasks such as 
the radial arm task (Luine et al., 1994). This same effect is evident in spatial memory when 
BDNF is deleted in the hippocampus. This neurotrophic factor has a large role in the 
hippocampus, which is thought to be linked to plasticity, and thus, learning and memory (Hall, 




Thomas & Everitt, 2000). BDNF has increased expression following hippocampal-dependent 
tasks, suggesting it has a critical role in these functions. BDNF is responsible for the growth of 
neurons in the hippocampus as well as the cortex, so its importance extends beyond its role in the 
hippocampus.  This protein is necessary for brain development, as well as modulating aspects 
such as cell survival, differentiation, synaptogenesis and cell migration (Greenberg et al., 2009). 
Downregulation of BDNF is implicated in depression and stress-related pathology in the 
hippocampus, particularly in the dentate gyrus (Gronli et al., 2006). The effect of stress on 
neurophysiology and microscopic structures is expansive, and BDNF is only an example of the 
many involved proteins.  
 
Stress and other structures in the brain 
 There are many more effects of stress than the ones outlined above in the hippocampus, 
and activity of p38 and GSK3 underlies some of these changes as well. The hypothalamus-
pituitary-adrenal (HPA) axis plays a large role in stress regulation, and it is seen that the 
amygdala can activate this axis. The medial prefrontal cortex, which functions in emotional 
processing, plays a role in the inhibition of the HPA-axis, which is necessary for regulation of 
the stress response as overactivity is indicated in depression (Ostrander, Richtand & Herman, 
2003). The HPA-axis responds to glucocorticoids, and their receptors are regulated by p38 
MAPKs in that activation of this kinase leads to reduced GR function (Wang, Wu & Miller, 
2004). This suggests that p38’s role in this brain pathway is to limit its activity. Considering 
what happens as a result of overactivity in the HPA-axis, p38’s role is similar here to its role in 
apoptosis. It seems to block functions before they turn into disease pathologies. With this in 
mind, one would predict that p38’s role in GSK3 would be to prevent its overactivity from 




becoming a problem, but given current evidence it may seem that the inactivation is either 
insufficient or too delayed. 
 Pituitary adenylate cyclase-activating peptide (PACAP) is increased following repeated 
stress exposure in the bed nucleus of the stria terminalis (BNST), which is involved in regulation 
of the HPA-axis. Increasing PACAP leads to both anxiety-type behaviors and an increase in 
HPA-axis activity (Lezak et al., 2015).  With use of a p38 inhibitor it was noted that p38 is 
important in the activation of PACAP (Taylor et al., 2013). The studied functioning of PACAP, 
links it to be a psychological stress responder and subsequently shows a mental-health related 
behavior, suggesting that stress is the cause of the behavior. This taken in tandem with the 
observation of p38’s role in PACAP regulation provides further links of p38 to both 
psychological stress and the consequent behavior. The BNST is a limbic forebrain structure that 
connects this region to hypothalamic and brainstem regions to carry out neuroendocrine and 
other functions. High levels of p38 are observed in this brain region, though are not ubiquitous 
and are only in specific types of neurons (Type III).  STEP neurons are also found in this region, 
and together with p38 may function to regulate synaptic plasticity specifically in the BNST 
(Dabrowska et al., 2014). 
 
Figure 8. (Radley et al., 2008) 
This figure shows an 11% loss in apical and basal 
dendritic density in stressed animals. The stressor used 
was restraint stress, which was used for six hours a day 
over the course of three weeks (Radley et al., 2008). 
This reduced density following psychological stress 




could possibly be mediated by stress-activated phosphorylation of p38, as a marker of synapses 
was noted to be decreased in correlation to where p38 was activated (Liu et al., 2003). 
 
There are many known gross anatomical effects of mental stress and illness as well, most 
notably in the brain, where an MRI will reveal differences, such as a reduced hippocampal size 
in depressed individuals and those with PTSD (Bonne et al., 2001). Given what is known about 
how DNA damage affects cellular processes, this finding of reduced hippocampal size is 
possibly due to over expression of apoptotic mechanisms, such as GSK3 and p38, leading to 
neurodegeneration. The effect of stress on the brain, including decreased neurogenesis, has led 
some to conclude that chronic stress is in itself a “mild neurodegenerative disease” (Duman, 
2014). While chronic stress is thus commonly thought of as the problem, even acute, or short-
term, stress can create changes in the brain (Brown, Henning & Wellman, 2005).  In other words, 
stress, no matter its duration, can be detrimental and it is important to develop a better 
understanding of these effects, so that improved prevention and treatment can be created. P38 is 
widely implicated in neurodegenerative disease, and inhibition of p38 signaling can prevent 
axonal degradation, which occurs commonly at the onset of these diseases (Dapper, Crish, Pang 
& Calkins, 2013). These two ideas would suggest that p38 has a role in the decreased 
neurogenesis seen as a result stress. 
  
Stress, mental illness and neurodegenerative disease 
Observing roles of p38 and GSK3 in neurodegenerative diseases provides further 
evidence that these kinases are involved in both the brain changes and resulting behavior seen 
after stress and in mental illness. With a growing population, neurodegenerative diseases are 




becoming increasingly common on their own, and studies detailing specifics of these diseases 
and their brain changes draws certain parallels to brain changes in depressed individuals. 
Neurodegenerative diseases are marked by progressive neuronal death, and are, at this point, 
incurable, including diseases such as Alzheimer’s, schizophrenia, and Parkinson’s. Alzheimer’s 
disease (AD), while still a large focal point of research, is generally thought to be caused in some 
way by protein aggregates. This causes brain changes such as neuronal death, decreased volume, 
and disrupted synaptic communication, leading to issues in cognition, particularly memory, in 
AD. Depression causes neuronal atrophy, focally decreased brain volume, and disruption in 
circuitry, leading to similar, though usually less severe functional deficits. BDNF has been 
implicated in depression, as mentioned previously, and there is also a link between this protein 
and AD. In autosomal dominant AD, one copy of the BDNF Met66 allele increased severity of 
memory impairment, and this polymorphism is known to reduce BDNF expression by about a 
third (Lim et al., 2016). Another study found that tau, which is the protein that causes 
neurofibrillary tangles in AD, seems to cause a down-regulation of BDNF, further implicating its 
role in the disease (Rosa et al., 2016). The evidence provided in this paper shows that p38 is 
activated in response to stress, both cellular and psychological. It has also shown that there are 
behavioral correlates of this activation, known in neurodegenerative diseases, and the phenotypes 
are similar to those of various mental disorders. P38 and GSK3 as the underlying mechanism in 
mental illness would provide a possible mechanism for the transition of mental illness to severe 
neurodegenerative diseases, such as Alzheimer’s, which has been noted to be higher in depressed 
populations. It is possible that when there is dysregulation for such a long period of time, p38 
and GSK3’s effect becomes so severe, that the resulting apoptosis is significant and irreversible, 
as seen in neurodegenerative diseases. 




Just as BDNF is not the only difference in stressed brains compared to healthy 
counterparts, BDNF is not the only biochemical link between depression and neurodegenerative 
diseases. A postmortem study of patients with depression found increased concentrations of 
superoxide dismutase, which was likely a response to an increased amount of oxidative stress 
(Michel et al., 2007). Using animal models in the context of social defeat and a radial arm task, 
an association was found between anxiety-like behaviors, memory impairment and elevated 
oxidative stress biomarkers (Patki et al., 2013). Oxidative stress has been implicated in 
neurodegenerative diseases as well, with a theory suggesting that the free radicals are a huge 
factor in their pathogenesis (Rao & Balachandran, 2002). The age of onset may explain part of 
the reason why there are free radicals in brains of patients with AD, but these levels are higher 
than age matched controls, so it is more likely due to the disease itself. Sleep disturbances 
apparent in stress and depression may provide reasoning behind the increase in oxidative stress, 
as sleep is when your brain typically flushes the reactive oxygen species. Much like BDNF, the 
presence of these chemicals may be responsible to some of the symptoms that depression shares 
with AD. 
Depression in older individuals has been associated with more significant cognitive 
impairment, with studies finding impairment a year after treatment in individuals who had no 
impairment prior to depression diagnosis. The hippocampus of depressed individuals as well as 
animal models of stress have decreased volume compared to healthy counterparts, and the 
hippocampal dysfunction is thought to be why a common issue in depression, as well as with 
stress and various neurodegenerative diseases, is a marked difficulty with memory. Other studies 
have found depression to increase the risk of developing AD later (Butters et al., 2008). It is 
unclear whether or not depression is a cause of AD, a risk factor for AD, or if it causes 




symptoms of AD to present earlier than usual; any of these explanations would help support the 
concept that depression is a mild neurodegenerative disorder with similar underlying pathologies. 
There is a debate in AD research about education’s effect on the disease, arguing about 
whether or not having more education acts as a cognitive reserve or not. The argument stems 
from the finding that those with higher education have a lower incidence of dementia and AD, 
and researchers hypothesize that this may be due to stronger connections, plasticity and other 
processes strengthened by learning being more resilient to dysfunction. Parallel to this would be 
having more connections in general allowing an equal loss of neurons without as much of an 
effect, due to the relative proportion. While many studies have provided evidence of the 
cognitive reserve being a preventative factor, studies also show that a larger cognitive reserve is 
associated with a more rapid decline, and an earlier AD related death (Stern, 2013). 
There is of course the possibility that a confounding variable, such as stress level or 
nutrition, is the reason why those with higher education have a lower risk of developing AD, as 
higher education is typically associated with a higher income, thus better nutrition and less 
financial stress. Even these explanations, though would point to deleterious effects, such as from 
malnutrition, being the cause of a higher incidence of AD in those with less education, which 
could still arguably be considered in line with the cognitive reserve hypothesis. This would still 




Symptoms of stress, such as change in eating and sleep habits, poor concentration and 
decreased immune function are also symptoms of many mental illnesses. Similar changes in 




behaviors and similar symptoms could be the result of like changes in brain activity and 
anatomy, providing further evidence of how stress may commonly be a predecessor to mental 
disorders. Given the role of underlying mechanisms in some of these symptoms, it could be 
worthwhile to consider them in part to be underlying etiology in mental illness. P38 MAPK has 
long been studied as a key factor in the stress response, and data shows that it is activated by 
psychological stress, just as it is in response to cellular stress. This suggests that both of these 
types of stress are similar as far as the body’s reaction goes. It would also offer that the 
downstream activity is the same, as data has shown psychological stress leads to degeneration, 
and it is seen that activating p38 and GSK3 are seen to cause apoptosis when activated by 
cellular stress (Hare, 2015). This upregulation of the kinases activity is associated with behaviors 
that mimic phenotypes of mental illness, such as exaggerated fear (Hare, 2015). The response 
created by GSK3 and p38 could underlie mental disorder pathology given this evidence, and 
would also imply that stress precedes mental illness, which has been previously supported by 
some research. GSK3 is more specifically regulated by p38 in the brain, suggesting a paired role 
of the two in brain-related function and illness. If findings are consistent with the S389 site also 
being a site of inhibition, there are several possibilities that could explain why phosphorylating 
GSK3 would still lead to the apoptosis seen in overactivity. The degeneration that may result 
could be the result of cellular death instead of apoptosis, which possibly occurs due to damage 
being significant enough, but without GSK3 activity the death cannot be properly regulated. 
Other theories would include previously mentioned ideas of overcorrection or a tenuous balance 
system. 
YH2AX is an indicator of DNA damage, and is seen to be increased in response to a 
variate stress paradigm, indicating that psychological stress can create DNA damage, though it is 




unclear what pathway leads between these two occurrences. This was seen in a significant 
amount in the BNST, which is an area known to have a role in the stress response. The DNA 
damage also increased p38 phosphorylation, which subsequently inhibited GSK3. When GSK3 
is active, there is evidence of DNA repair, and following DNA damage, the activity of GSK3 in 
the nucleus is not linked to serine 9, suggesting the activity may occur at the novel S389 site 
specifically (Hare, 2015). Exactly what role this damage is meant to play is unclear, as it could 
be a role in plasticity, or it could just be one of the quickest ways to carry out apoptosis when the 
cell is under stress. The DNA could create the double strand breaks in attempt to alter its protein 
expression, just as it does in the development of the adaptive immune response, but at this point 
it would be difficult to discern this as the role without more supporting evidence. In summation, 
evidence provided so far in this review leads to the conclusion that psychological stress precedes 
p38 activation and then phosphorylation of GSK3, and that this activity leads to physical changes 
such as degeneration and observable phenotypes such as exaggerated fear. This prolonged and 
exaggerated fear is indicative of anxiety and neuronal degeneration has been seen in depression, 
as well as in brain diseases with similar symptoms. On the surface level, stress seems to precede 
mental illness with DNA damage, GSK3, and p38 activity underlying the pathology that creates 
these behavioral and physiological changes. The DNA damage created as a response to 
psychological stress needs to be studied further, as it is currently unclear whether this would 
precede or follow p38 and GSK3 activity, though, given p38 and GSK3’s role in DNA repair and 










Importance and Future Directions 
 
Existing theories of mental disorder etiology 
There are theories in psychiatry surrounding etiology, and many of them are centered 
around stress, such as the HPA-axis theory of depression. This is an older theory that states 
depression is caused by HPA hyperactivity. The HPA is regulated by glucocorticoids, which are 
elevated in response to stress. This then causes overactivity of the HPA and this dysregulation 
can be lasting, as HPA activity is seen to be abnormal in various mental illnesses. The HPA is 
known to regulate functions such as neurogenesis and the immune system. This theory explains 
much about depression, and indicates a reason for why stress is considered to be the most 
common cause of the illness. While this theory has a lot of evidence, a need for something more 
specific needs to be found in order for any pharmaceutical treatments to be used. There is 
evidence that p38 injection leads to an acute increased response of the HPA, suggesting this 
kinase could be a part of this theory, which currently holds a lot of support (Felger et al., 2012).  
Studies with brain imaging have shown decreased volume in depressed individuals 
comparatively to healthy counterparts, and this is part of the evidence behind the neurotrophic 
theory. This theory focuses on neurogenesis, and states that decreased activity of factors 
involved in neurogenesis is the cause underlying depressive symptoms.  It is thought that the 
decrease in new growth and synaptic connections, and this theory is supported by various 
mechanisms of antidepressants. BDNF and GSK activity are linked as already described, and 
evidence also shows that p38 activation is required for BDNF activity as well (Katoh-Semba et 
al., 2009). 




These theories are reasonable, and are probably accurate, though seem inadequate given 
they haven’t yet resulted in more efficacious treatments. A lot of them are related to processes 
and factors that are related to stress pathology, suggesting that studies were already leaning 
towards a stress-induced model of mental illness. Shifting the focus to kinases like p38 could 
actually combine these theories, and hopefully develop improved understanding and create novel 
treatments.  
 
New theories and psychiatry 
Understanding the underlying mechanisms of mental illness can lead to advancements in 
psychiatry. Currently, there are many medications, in a few different categories, divided up by 
their mechanism of action. Selective serotonin reuptake inhibitors, monoamine oxidase and 
tricyclic antidepressants are some of the categories of antidepressants that are used frequently. 
While some are effective for some people, it is exceptionally difficult to find the right medication 
at times. There are many external and internal factors that can lead to mental health problems, 
and given the diversity in onset, and the poor understanding it would not be viable for the 
existing medications to be effective in all cases. This range of causes in mental illness would 
provide support for a need in a high diversity of psychopharmaceuticals. This is on top of the fact 
that side effects of current medications can be severe, such as lithium toxicity or neuroleptic 
malignant syndrome. 
Current antidepressants currently take about two weeks to be effective, and in this period 
of time can increase symptoms of depression, such as suicidality, which prevents a lot of people 
from continuing to take the medication long enough for them to have their desired effect. A lot of 
medications are also rather sedating, which can be problematic, and may entice people to try and 




use these drugs for overdose. Of course, this could be an issue with any medication, but 
searching for novel drug targets could result in the finding of safe and effective drugs, even in 
overdose. 
The finding that p38’s phosphorylation of GSK3𝛽at serine 389 may underlie various 
pathologies could become a novel drug target site. While there are many stories of recovery from 
mental illness, there are also a lot of relapses, which should encourage further research. One of 
the biggest risk factors of suicide, as well as psychiatric hospitalization, is prior suicide attempts 
and prior hospitalization, respectively. Prevention seems like it would be the best way, with 
particular respect to mental illness, as many illnesses can severely interfere with motivation to 
recover. It does not seem plausible that all mental disorders could be prevented all the time, but 
better understanding of the disease course and its cause could lead to better therapies, and more 
research surrounding stress reduction, which could be key in treating mental health disorders. 
 
Implications outside of psychiatry  
 The understanding that stress specifically is the preceding factor in this mechanism 
leading to mental illness can help prevention efforts and make people more aware of the 
profound effect various things can have on their well-being. The ties of this research in 
psychiatric treatment are clear, but it also builds upon the research of psychological stress felt by 
every individual, even those without mental illness. This knowledge of what stress can do to the 
brain may help people be more mindful of their stress in addition to how their actions can affect 
others.  
There is a lot of evidence that links stress to mental illness, including behavioral 
responses being similar, anatomical brain changes appearing the same, and underlying 




physiology, namely p38 and GSK3 being indicated in both mental disorders and psychological 
stress. Currently, there is a large stigma placed upon psychiatric illnesses, which places an 
unnecessary added stress unto individuals. This stigma both prevents many from seeking 
treatment, and given the information outlined above, could worsen or exacerbate the illness. The 
effects of stigma, and by extension, hatred appears to have the ability to cause observable 
changes in physiological and anatomical processes.  
 This can be supported by the incidence of mental illness being higher in suppressed 
populations, such as racial minorities and in communities like the LGBT. It could also point to 
part of the reason why psychiatric disorders are often comorbid with stigmatized illnesses, such 
as HIV or epilepsy. Epilepsy, in particular, should be considered when thinking about 
neurophysiological effects of stress due to the fact that stress is a known trigger of seizures, 
providing more tangible support for biological effects of stress. Having biological links to 
behaviors, and therefore behavioral and psychological illnesses may help to mitigate some of the 
stigma surrounding mental health. A lot of people seem to think that mental illness is indicative 
of a person being weak or lazy, so having empirical evidence, such as p38 or GSK3 expression, 
that this is in fact not the case may help reverse some of these misconceptions. 
Epilepsy, while still stigmatized, has had large improvements in public perceptions, 
potentially assisted by the fact there has been physical causes of the disorder. Illnesses with 
visible, physical effects are rarely stigmatized, especially in comparison to mental illnesses, so it 
is reasonable to believe that finding hard evidence of bodily mechanisms behind mental health 
would reduce this stigma. Changing the public’s perception can foreseeably help people seek 
treatment when they need it, as well as reduce the added stress of having a stigmatized illness. 




Considering the variety that exists in mental illnesses, and the differences present 
between each and every human, it would not be prudent to state that stress is always a precursor 
for mental illness. This does not mean that stress should not be studied, as it is clear that data is 
pointing toward stress being a huge factor for a large portion of mental health disorders. If stress 
and associated brain changes are a common cause, then recognizing stress early, and treating the 
stress is critical to saving people from dealing with these illnesses. Being able to prevent 
depression, anxiety and other illnesses before they began could be both life-changing and life-
saving for so many people. 
  
Further research 
The literature on p38 is vast, but it mainly focuses on cellular stress and p38’s role in the 
response to toxic external mechanisms, such as UV light. It is frequently found in research 
regarding cancer, and the literature on p38’s relationship to variate stress or conditioned fear is 
not extremely well rounded. There are many studies that could be performed in attempts to fill in 
potential gaps in linking p38 to mental illness. Using a stress paradigm, it would be beneficial to 
test freezing to tone and novel context after tone-shock comparing, and compare a control group 
to those who have p38 inhibitors on board. It would be important to repeat the study in several 
rounds, administering the drug at different times, such as before stress, before training, or during 
testing. This would help to parse out p38’s specific role in these anxiety-type behaviors, as well 
as provide information about timing of activation. It would be predicted that if p38 is prevented 
from being phosphorylated, then there will be more freezing in both the stressed and control 
groups, but the change will be more drastic in the stressed group receiving the inhibitor. It would 
be prudent to repeat this study, but with mice that are knocked out for GSK serine 389 so that it 




could be determined whether the observed effect is due to general p38 activity, or specifically its 
activity at serine 389. GSK3b knockout studies need to be observed further, as currently studies 
with knockout mice for this kinase are not viable due to apoptosis in regions outside of the brain 
(Hoeflich et al., 2000). It would be helpful to specifically knockout this kinase in the brain to 
determine what its role when totally inactivated would be. 
Observing histological samples for double strand breaks after stress would be of use as 
well, and taking samples right after stress, and then after vehicle or p38 inhibitor administration 
would help specify p38’s role in DSBs, as well as if they exist after psychological stress. The 
experiments discussed in this paper that focused on GSK, DNA damage and behavioral stress 
responses utilized knockin mice that had constitutively active GSK. This means that the effects 
observed may be due to a difference in the development of these mice compared to wild type. 
Using a p38 inhibitor, to block phosphorylation of GSK, thus keeping it active would allow 
observation of the specific effects and bypass any possible developmental effects. Observing the 
expression of p38, GSK3 and double strand breaks in postmortem studies of humans with 
various mental illnesses would be necessary to bring a lot of this research’s relevance to humans. 
While animal models are extremely helpful in studies, basing everything off them before creating 
new treatments would be unwise, so ensuring expression of these kinases, and the presence of 
DNA damage in the brain would be key to tying this mechanism firmly to mental disorder 
pathology. 
 The novel serine site of GSK3b should be further explored as well. A downstream target 
should be observed in response to inducing phosphorylation by p38 at the novel site. This would 
help to determine whether phosphorylation at serine 389 is inhibitory as serine 9 is, or if it is 
excitatory. Inducing apoptosis and then selectively blocking serine 9 or serine 389 could help 




determine the latter site’s role in apoptosis. To test if the function is more specific, DSB-induced 
apoptosis should be used and compared to other apoptosis-inducers.  
 Considering self-reports of stress relief while engaging in various activities, it could be 
useful to observe the effects of the activities on these pathways. For example, exercise is a stress 
reducer, which is known to have a plethora of benefits universally through the body. It has been 
researched in the context to help mitigate the progression of dementia, and considering the link 
of neurodegenerative disease, stress and kinases such as p38 and GSK3, these kinases may be 
involved in the beneficial effects during exercise. If the effects are consistent with regulation of 
p38 and GSK3, then developing specific exercise regimes to best benefit them could be created, 
and could be used as prevention and treatment of mental illness or even neurodegenerative 
disease. This would be a favorable alternative to many over pharmaceuticals to treat their illness, 
and could lead to overall improvements in health, which will tie back into general stress relief as 
health and accompanying financial burden can be huge stressors. 
 
Conclusions 
 There is an abundance of data tying p38 to various types of cellular stress, and a 
common end result of this response is cellular death. GSK3 also has a lot of evidence to link it to 
functioning in cellular death specifically in response to stress. The particular response of these 
kinases to DNA damage and this novel serine site of GSK imply that specifically this type of 
stressor may underlie many pathologies, from neurodegenerative diseases to mental illnesses. 
Many behaviors in response to stress are reminiscent of symptoms in mental illness as well as 
neurodegenerative disease, and many brain effects are similar as well. Taking the combination of 
research presented here, one could propose a model of mental illness, which occurs as a result of 




stress. This stress creates changes in expression of kinases and DNA damage, which then carry 
out apoptosis, underlying atrophy observed in the mentally ill, stressed patients, and 
neurodegenerative disease, helping to make sense of why observable behaviors in each have so 
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